Cargando…
Progression-free survival and quality of life in metastatic breast cancer: The patient perspective
INTRODUCTION: Treatment advances for metastatic breast cancer (mBC) have improved overall survival (OS) in some mBC subtypes; however, there remains no cure for mBC. Considering the use of progression-free survival (PFS) and other surrogate endpoints in clinical trials, we must understand patient pe...
Autores principales: | Mertz, Shirley, Benjamin, Christine, Girvalaki, Charis, Cardone, Antonella, Gono, Paulina, May, Suepattra G., Comerford, Erin, Than, Kyi-Sin, Birch, Kelly, Roach, Meaghan, Myers, Sky, Sasane, Medha, Lavi, Liat, Cameron, Anna, Cardoso, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307669/ https://www.ncbi.nlm.nih.gov/pubmed/35870420 http://dx.doi.org/10.1016/j.breast.2022.07.006 |
Ejemplares similares
-
Adoption of Digital Health Technologies in the Practice of Behavioral Health: Qualitative Case Study of Glucose Monitoring Technology
por: May, Suepattra G, et al.
Publicado: (2021) -
Education for a tobacco free world: the 11(th) meeting of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)
por: Vardavas, Constantine, et al.
Publicado: (2014) -
Are political views related to smoking and support for tobacco control policies? A survey across 28 European countries
por: Filippidis, Filippos T., et al.
Publicado: (2017) -
Social responsibility during the COVID-19 pandemic: Tobacco industry’s trojan horse in Europe
por: Girvalaki, Charis, et al.
Publicado: (2020) -
Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data
por: Lang, Kathleen, et al.
Publicado: (2014)